flucytosine - search results

United States - English - NLM (National Library of Medicine)

flucytosine capsule

bryant ranch prepack - flucytosine (unii: d83282dt06) (flucytosine - unii:d83282dt06) - flucytosine capsules are indicated only in the treatment of serious infections caused by susceptible strains of candida and/or cryptococcus . candida: septicemia, endocarditis and urinary system infections have been effectively treated with flucytosine. limited trials in pulmonary infections justify the use of flucytosine. cryptococcus: meningitis and pulmonary infections have been treated effectively. studies in septicemias and urinary tract infections are limited, but good responses have been reported. flucytosine capsules should be used in combination with amphotericin b for the treatment of systemic candidiasis and cryptococcosis because of the emergence of resistance to flucytosine capsules (see microbiology ). flucytosine capsules are contraindicated in patients with a known hypersensitivity to the drug. flucytosine capsules are contraindicated in patients with known complete dihydropyrimidine dehydrogenase (dpd) enzyme deficiency (see warnings ).

United States - English - NLM (National Library of Medicine)

flucytosine capsule

United States - English - NLM (National Library of Medicine)

ancobon- flucytosine capsule

bausch health us llc - flucytosine (unii: d83282dt06) (flucytosine - unii:d83282dt06) - flucytosine 250 mg - ancobon is indicated only in the treatment of serious infections caused by susceptible strains of candida and/or cryptococcus . candida: septicemia, endocarditis and urinary system infections have been effectively treated with flucytosine. limited trials in pulmonary infections justify the use of flucytosine. cryptococcus: meningitis and pulmonary infections have been treated effectively. studies in septicemias and urinary tract infections are limited, but good responses have been reported. ancobon should be used in combination with amphotericin b for the treatment of systemic candidiasis and cryptococcosis because of the emergence of resistance to ancobon (see microbiology ). ancobon is contraindicated in patients with a known hypersensitivity to the drug. ancobon is contraindicated in patients with known complete dihydropyrimidine dehydrogenase (dpd) enzyme deficiency (see warnings).

United States - English - NLM (National Library of Medicine)

flucytosine powder

bluebay shandong co.,ltd - flucytosine (unii: d83282dt06) (flucytosine - unii:d83282dt06) -

United States - English - NLM (National Library of Medicine)

ancobon flucytosine capsule

cardinal health - flucytosine (unii: d83282dt06) (flucytosine - unii:d83282dt06) - flucytosine 500 mg